Brief: ENDRA Life Sciences - Enters First Amendment To Merger Agreement On October 1, 2026 - SEC Filing
01/10/2026 23:19
BRIEF-ENDRA Life Sciences - Enters First Amendment To Merger Agreement On October 1, 2026 - SEC Filing Oct 1 (Reuters) - ENDRA Life Sciences Inc NDRA.O:
ENDRA LIFE SCIENCES - ENTERS FIRST AMENDMENT TO MERGER AGREEMENT ON OCTOBER 1, 2026 - SEC FILING
ENDRA LIFE SCIENCES - RENERGEN BORROWING CAPACITY FROM ASPI INCREASED TO $120 MILLION - SEC FILING
ENDRA LIFE SCIENCES - RENERGEN BORROWING CAPACITY FROM ASPI TO BE INCREASED TO $200 MILLION - SEC FILING
Source text: [ID:n0001213900-26-105899]
Further company coverage: NDRA.O
((((Reuters.Briefs@thomsonreuters.com;));))
Recent news on ENDRA Life Sciences
See all newsBrief: ENDRA Life Sciences - Enters First Amendment To Merger Agreement On October 1, 2026 - SEC Filing
ENDRA Life Sciences posts Q2 profit on digital asset gains ahead of merger
Endra Life Sciences Inc Reports Results For The Quarter Ended June 30: Earnings Summary
Endra Life Sciences Inc Expected To Post A Loss Of 84 Cents A Share: Earnings Preview
Brief: ASP Isotopes Announces Proposed Merger Of Noble Africa With Endra Life Sciences